Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:
SAN DIEGO , Nov. 26, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that members of its senior management team will participate at the upcoming investor conferences: Evercore ISI HealthCONx Conference – Presenting on Tuesday, December 3 , at 11:00 AM ET in Boston
- Arena received the 2019 Deal of the Year Award for its global licensing agreement with United Therapeutics for ralinepag, a prostacyclin receptor agonist, in development for the treatment of pulmonary arterial hypertension (PAH) SAN DIEGO , Nov. 18, 2019 /PRNewswire/ -- Arena Pharmaceuticals,